Mostrando
1
al
20
de
26
resultados
ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2023-DISEASE-07
The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado
2024-08-20 - 2031-08-31 | Financiado
CT-Luso: Ethics and Regulatory Capacity Building Partnership for Clinical Trials in Portuguese speaking Afric...
CT-Luso intends to (1) draw an updated diagnosis and screenshot of the research ethics infrastructure in the 5 Portuguese-speaking African C...
2024-07-25 - 2027-12-31 | Financiado
2024-07-25 - 2027-12-31 | Financiado
4P-CAN: Personalized CANcer Primary Prevention research through Citizen Participation and digitally enabled...
With a strong belief that primary prevention of cancer represents a collective responsibility (citizens, professionals, decision-makers), du...
2023-04-24 - 2027-04-30 | Financiado
2023-04-24 - 2027-04-30 | Financiado
MOBVEC: Mobile Bio-Lab to support first response in Arbovirus outbreaks
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
HORIZON EUROPE:
HORIZON-EIC-2022-PATHFINDEROPEN-01
The WHO estimates that vector-borne diseases (VBD) account for more than 17% of all infectious diseases. Every year, more than 2.5 billion p...
2022-12-15 - 2027-06-30 | Financiado
2022-12-15 - 2027-06-30 | Financiado
PARC: Partnership for the Assessment of Risks from Chemicals
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2021-ENVHLTH-03
PARC is an EU-wide research and innovation partnership programme to support EU and national chemical risk assessment and risk management bod...
2022-05-24 - 2029-04-30 | Financiado
2022-05-24 - 2029-04-30 | Financiado
ISIDORe: Integrated Services for Infectious Disease Outbreak Research
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
HORIZON EUROPE:
HORIZON-INFRA-2021-EMERGENCY-02
The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest...
2022-02-09 - 2025-07-31 | Financiado
2022-02-09 - 2025-07-31 | Financiado
PANDEM-2: Pandemic Preparedness and Response
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
H2020:
H2020-SU-SEC-2018-2019-2020
PANDEM-2 implements and demonstrates the most important novel concepts and IT systems to improve the capacity of European pandemic planning...
2020-11-30 - 2023-07-31 | Financiado
2020-11-30 - 2023-07-31 | Financiado
B1MG: Beyond 1M Genomes
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
H2020:
H2020-SC1-DTH-2018-2020
The Beyond 1 Million Genomes (B1MG) consortium will establish the support and coordination structure for the European 1+ Million Genomes ini...
2020-06-04 - 2023-10-31 | Financiado
2020-06-04 - 2023-10-31 | Financiado
I-MOVE-COVID-19: Multidisciplinary European network for research prevention and control of the COVID 19 Pandemic
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
H2020:
H2020-SC1-PHE-CORONAVIRUS-2020
I-MOVE-COVID-19 aims to obtain epidemiological, clinical and virological information about COVID-19 and patients infected with SARS-CoV-2, t...
2020-04-08 - 2022-06-15 | Financiado
2020-04-08 - 2022-06-15 | Financiado
METROFOOD-PP: METROFOOD RI Preparatory Phase Project
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
H2020:
H2020-INFRADEV-2018-2020
METROFOOD-RI – Infrastructure for Promoting Metrology in Food and Nutrition - is a pan-European Research Infrastructure (RI) aimed to promot...
2019-11-20 - 2022-05-31 | Financiado
2019-11-20 - 2022-05-31 | Financiado
VECTRACK: Earth observation service for preventive control of insect disease vectors
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
H2020:
H2020-EIC-FTI-2018-2020
During the summer of 2018, the EU experienced the worst outbreak of West Nile Virus (WNV) in history, with more than 1317 infected and 142 d...
2019-05-15 - 2023-04-30 | Financiado
2019-05-15 - 2023-04-30 | Financiado
EJP RD: European Joint Programme on Rare Diseases
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
H2020:
H2020-SC1-BHC-2018-2020
As recognized by the Council Recommendation 2009/C 151/02, rare diseases (RD) are a prime example of a research area that can strongly profi...
2018-12-13 - 2024-08-31 | Financiado
2018-12-13 - 2024-08-31 | Financiado
ERINHA-Advance: Advancing European Research Infrastcuture on Highly Pathogenic Agents
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
H2020:
H2020-INFRADEV-2018-2020
One of the great challenges of the 21st century is to develop the capacity to prevent and react to outbreaks caused by highly pathogenic hum...
2018-11-20 - 2022-06-30 | Financiado
2018-11-20 - 2022-06-30 | Financiado
One Health EJP: Promoting One Health in Europe through joint actions on foodborne zoonoses antimicrobial resistance...
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
H2020:
H2020-SFS-2016-2017
The One Health concept recognizes that the human health is tightly connected to the health of animals and the environment, i.e. that animal...
2017-10-09 - 2023-09-30 | Financiado
2017-10-09 - 2023-09-30 | Financiado
PRO-METROFOOD: Progressing towards the construction of METROFOOD RI
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
H2020:
H2020-INFRADEV-2016-2017
The general objective of PRO-METROFOOD is to bring the emerging METROFOOD-RI ESFRI project to the level of maturity required for entering in...
2016-12-13 - 2017-12-31 | Financiado
2016-12-13 - 2017-12-31 | Financiado
EUROlinkCAT: EUROlinkCAT Establishing a linked European Cohort of Children with Congenital Anomalies
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
H2020:
H2020-SC1-2016-2017
Over 130,000 children born in Europe every year will have a congenital anomaly (CA; birth defect). These CAs, which are often rare diseases,...
2016-12-12 - 2022-05-31 | Financiado
2016-12-12 - 2022-05-31 | Financiado
HBM4EU: European Human Biomonitoring Initiative
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
H2020:
H2020-SC1-2016-2017
The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemi...
2016-12-09 - 2022-06-30 | Financiado
2016-12-09 - 2022-06-30 | Financiado
ERINHA2: European Research Infrastructure on Highly Pathogenic Agents 2
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
H2020:
H2020-INFRADEV-2014-2015
ERINHA2 aims to complete the work carried out during the first preparatory phase (PP1) - ERINHA - in order to reach the financial, administr...
2015-10-08 - 2017-06-30 | Financiado
2015-10-08 - 2017-06-30 | Financiado
I-MOVE-plus: I MOVE Integrated Monitoring of Vaccines Effects in Europe a platform to measure and compare effec...
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
H2020:
H2020-PHC-2014-2015
The I-MOVE+ Consortium includes European Union (EU) Public Health Institutes, SME and Universities. It aims at measuring and comparing the e...
2015-04-07 - 2018-10-31 | Financiado
2015-04-07 - 2018-10-31 | Financiado
COMBACTE-NET: Combatting Bacterial Resistance in Europe
INSTITUTO NACIONAL DE SAUDE DR. RICARDO JORGE
participó en un
FP6:
The emergence of Antibiotic-resistant bacteria (ARB) is a global problem, having recently been elevated to the top three threats identified...
2013-01-01 - 2021-02-28 | Financiado
2013-01-01 - 2021-02-28 | Financiado
* No se disponen de datos de la empresa actual.